PMID 22529954
Theres no studies yet to show why this may be - whether its the effect from intense cardio or whether those who enjoy running more commonly have a naturally higher metabolism - and it doesnt seem to happen for all runners
Moreover, double-check payer-specific rules for frequency limits, bundling, and supervision requirements before submission
The danger increases with the degree of the shortage
They'll likely schedule recommended blood tests to monitor your B12 levels, discuss any persistent or new symptoms, review your injection technique periodically, and adjust your injection schedule based on your results
Nausea (most common, typically dose-dependent and transient) Diarrhea or constipation during dose escalation Vomiting, especially when starting or increasing dose Reduced appetite and early satiety Injection site reactions (redness, bruising) Fatigue, particularly in early weeks Rare: Pancreatitis discontinue immediately with severe abdominal pain Rare: Thyroid C-cell effects (contraindicated with MEN2 or thyroid cancer history) AOD-9604 is a modified C-terminal fragment (residues 176191, Tyr-hGH177-191) of human growth hormone, studied for lipolytic and anti-obesity properties